Germany

Medlab Asia & Asia Health

Not Confirmed

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® S 12,5

Ingredient(s) : Methacrylic Acid Copolymer Type B

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Copolymer Type B

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® S 100

Applications : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® S 12,5

Grade : Oral

Looking for Controlled & Modified Release? Find methacrylic acid copolymer type b for stability, solubility & bioavailability enhancement on PharmaCompass.

Methacrylic Acid Copolymer Type B